404 related articles for article (PubMed ID: 19464901)
21. Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.
Brennan PE; Whitlock GA; Ho DK; Conlon K; McMurray G
Bioorg Med Chem Lett; 2009 Sep; 19(17):4999-5003. PubMed ID: 19646865
[TBL] [Abstract][Full Text] [Related]
22. A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.
Gopalakrishnan B; Aparna V; Jeevan J; Ravi M; Desiraju GR
J Chem Inf Model; 2005; 45(4):1101-8. PubMed ID: 16045305
[TBL] [Abstract][Full Text] [Related]
23. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
[TBL] [Abstract][Full Text] [Related]
24. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
[TBL] [Abstract][Full Text] [Related]
25. The development and validation of a novel virtual screening cascade protocol to identify potential serotonin 5-HT(7)R antagonists.
Kurczab R; Nowak M; Chilmonczyk Z; Sylte I; Bojarski AJ
Bioorg Med Chem Lett; 2010 Apr; 20(8):2465-8. PubMed ID: 20346662
[TBL] [Abstract][Full Text] [Related]
26. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
[TBL] [Abstract][Full Text] [Related]
27. Regulation of serotonin 5-HT2C receptors by chronic ligand exposure.
Devlin MG; Smith NJ; Ryan OM; Guida E; Sexton PM; Christopoulos A
Eur J Pharmacol; 2004 Sep; 498(1-3):59-69. PubMed ID: 15363976
[TBL] [Abstract][Full Text] [Related]
28. Using pharmacophore models to gain insight into structural binding and virtual screening: an application study with CDK2 and human DHFR.
Toba S; Srinivasan J; Maynard AJ; Sutter J
J Chem Inf Model; 2006; 46(2):728-35. PubMed ID: 16563003
[TBL] [Abstract][Full Text] [Related]
29. The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach.
Fan Y; Lai MH; Sullivan K; Popiolek M; Andree TH; Dollings P; Pausch MH
Bioorg Med Chem Lett; 2008 Nov; 18(21):5789-91. PubMed ID: 18849166
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT₂C agonists.
Conway RJ; Valant C; Christopoulos A; Robertson AD; Capuano B; Crosby IT
Bioorg Med Chem Lett; 2012 Apr; 22(7):2560-4. PubMed ID: 22381048
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel inhibitors of methionyl-tRNA synthetase (MetRS) by virtual screening.
Finn J; Stidham M; Hilgers M; G C K
Bioorg Med Chem Lett; 2008 Jul; 18(14):3932-7. PubMed ID: 18590962
[TBL] [Abstract][Full Text] [Related]
32. Structure-based virtual screening of Src kinase inhibitors.
Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
[TBL] [Abstract][Full Text] [Related]
33. Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor.
Salo OM; Raitio KH; Savinainen JR; Nevalainen T; Lahtela-Kakkonen M; Laitinen JT; Järvinen T; Poso A
J Med Chem; 2005 Nov; 48(23):7166-71. PubMed ID: 16279774
[TBL] [Abstract][Full Text] [Related]
34. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
[TBL] [Abstract][Full Text] [Related]
35. Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
Aloyo VJ; Berg KA; Spampinato U; Clarke WP; Harvey JA
Pharmacol Ther; 2009 Feb; 121(2):160-73. PubMed ID: 19109993
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.
Shimada I; Maeno K; Kondoh Y; Kaku H; Sugasawa K; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2008 Mar; 16(6):3309-20. PubMed ID: 18083579
[TBL] [Abstract][Full Text] [Related]
37. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
[TBL] [Abstract][Full Text] [Related]
38. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
[TBL] [Abstract][Full Text] [Related]
39. Use of an induced fit receptor structure in virtual screening.
Sherman W; Beard HS; Farid R
Chem Biol Drug Des; 2006 Jan; 67(1):83-4. PubMed ID: 16492153
[TBL] [Abstract][Full Text] [Related]
40. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
